KOL Data

Sales & Marketing

As biopharmas increasingly rely on AI and advanced data-driven technologies, evaluating the quality of data is critical.

Partner Content

how to navigate through KOL insights & management

Oncology

Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.